Literature DB >> 2358839

The effect of right atrial catheters on infectious complications of chemotherapy in children.

J van Hoff1, A T Berg, J H Seashore.   

Abstract

Rates of infections and catheter complications in children with right atrial catheters (RACs) receiving chemotherapy were compared with those without RACs in a retrospective cohort study. One hundred sixty-five children presenting to Yale-New Haven Hospital with a malignancy diagnosed between January 1, 1981 and December 31, 1985 were followed through June 30, 1986 for the number of treatment-related complications resulting in hospitalization. The time on therapy totaled 80,089 person-days that were divided into 510 periods of observation defined by the presence or absence of a RAC, disease status (remission, partial remission, or relapse), intensity of chemotherapy (using a 0 to 4 scale), and use of radiation therapy. Children with RACs experienced markedly higher rates of sepsis (14-fold higher, P less than .0001) and catheter-site infection or other catheter complications requiring hospitalization (both greater than 30-fold higher, P less than .0001). These effects persisted after controlling for other risk factors, ie, disease status, chemotherapy intensity, and age. Children with RACs also had higher rates of fever and neutropenia and other infections requiring hospitalization that were more strongly influenced by the other risk factors. The association of RACs with sepsis, fever and neutropenia, and days hospitalized for treatment-related complications was assessed using multivariable analysis methods to control for disease status, intensity of chemotherapy, radiation therapy, type of cancer, age, and sex. The presence of a RAC (rate ratio [RR], 6.39; P less than .0001) and the disease status (RR, 2.45; P = .0004) were the only factors that predicted sepsis. Fever and neutropenia rates were most influenced by chemotherapy intensity (RR, 2.31; P = .0001) and age (RR, 0.94; P = .013 per year of age) and less by the presence of a RAC (RR, 1.56; P = .053). Controlling for other risk factors, children with RACs experienced a 6.4-times higher rate of sepsis and spent an average of 15.4 more days per year in the hospital for treatment-related complications.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2358839     DOI: 10.1200/JCO.1990.8.7.1255

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  6 in total

1.  The prognostic significance of the ball-valve effect in Groshong catheters.

Authors:  B Tolar; J R Gould
Journal:  Support Care Cancer       Date:  1996-01       Impact factor: 3.603

2.  Morbidity using subcutaneous ports and efficacy of vancomycin flushing in cancer.

Authors:  H Rubie; M Juricic; S Claeyssens; A Krimou; J Lemozy; P Izard; J Guitard; M Ane; M F Prere; F Fedacou
Journal:  Arch Dis Child       Date:  1995-04       Impact factor: 3.791

3.  Closed-hub systems with protected connections and the reduction of risk of catheter-related bloodstream infection in pediatric patients receiving intravenous prostanoid therapy for pulmonary hypertension.

Authors:  D Dunbar Ivy; Michelle Calderbank; Brandie D Wagner; Susan Dolan; Ann-Christine Nyquist; Michael Wade; William M Nickels; Aimee K Doran
Journal:  Infect Control Hosp Epidemiol       Date:  2009-09       Impact factor: 3.254

4.  A prospective, randomized evaluation of the effect of silver impregnated subcutaneous cuffs for preventing tunneled chronic venous access catheter infections in cancer patients.

Authors:  J S Groeger; A B Lucas; D Coit; M LaQuaglia; A E Brown; A Turnbull; P Exelby
Journal:  Ann Surg       Date:  1993-08       Impact factor: 12.969

Review 5.  Administration of chemotherapeutic agents. Techniques and controversies.

Authors:  J H Raaf
Journal:  Support Care Cancer       Date:  1994-11       Impact factor: 3.603

6.  [Requirements for hygiene in the medical care of immunocompromised patients. Recommendations from the Committee for Hospital Hygiene and Infection Prevention at the Robert Koch Institute (RKI)].

Authors: 
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2010-04       Impact factor: 1.513

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.